David J. Back

18.5k citations
410 papers · 15.9k · 1 hit paper · h-index 66

Impact in

  • Virology top 0.1%
    • HIV Research and Treatment
    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions

Papers in

    • HIV/AIDS drug development and treatment 223
    • HIV/AIDS Research and Interventions 44
    • HIV Research and Treatment 108

David J. Back

406 papers receiving 15.1k citations

David J. Back's Hit Papers

Recommendations for the Management of Drug–Drug Interactions Between the COVID ‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications 2022 · 190 citations
1900+1+2Years since publication50100150

Peers

David J. Back
Comparison fields: 5 of 156
  • Virology 3.8k
  • Infectious Diseases 8.0k
  • Pharmacology 2.1k
  • Emergency Medicine 1.6k
  • Hepatology 1.1k
Replace David Marinus Burger with:
David Marinus Burger Netherlands
Saye Khoo United Kingdom
Angela D. M. Kashuba United States
Catia Marzolini Switzerland
Laurent Arthur Decosterd Switzerland
Tomáš Cihlář United States
Courtney Vail Fletcher United States
Giovanni Di Perri Italy
Andrew Owen United Kingdom
Edward P. Acosta United States
David J. Back relative to David Marinus Burger Netherlands David Marinus Burger's profile →
Citations per field
00.5×2×2.8×
David Marinus Burger · 1×
Citations per year

Countries citing papers authored by David J. Back

Since Specialization
Citations

This map shows the geographic impact of David J. Back's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Back with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Back more than expected).

Fields of papers citing papers by David J. Back

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Back. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Back. The network helps show where David J. Back may publish in the future.

Co-authors

The 25 scholars most cited alongside David J. Back, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David J. Back Line = papers co-authored together David J. Back links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 410 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2002579
2 1997307
3 1998303
4 1999253
5 2002232
6 1997232
7 1992217
8 2009213
9 1997211
10
Recommendations for the Management of Drug–Drug Interactions Between the COVID ‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications
Hit paper breakdown →
2022190
11 1990175
12 2009174
13 1997173
14 2002158
15 1983157
16 2003156
17 2008156
18 2010147
19 1999143
20 2020139

About David J. Back

David J. Back is a scholar working on Infectious Diseases, Virology, Pharmacology, Emergency Medicine and Hepatology, having authored 410 papers that have together received 15.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (223 papers), HIV Research and Treatment (108 papers), Drug Transport and Resistance Mechanisms (56 papers), Pharmacogenetics and Drug Metabolism (48 papers), HIV-related health complications and treatments (45 papers), HIV/AIDS Research and Interventions (44 papers), Pharmacological Effects and Toxicity Studies (43 papers) and Hepatitis C virus research (36 papers). The work is most often cited by research in Virology (3.8k citations), Infectious Diseases (8.0k citations), Pharmacology (2.1k citations), Emergency Medicine (1.6k citations) and Hepatology (1.1k citations). David J. Back has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Saye Khoo, Michael G. Barry, Andrew Owen, Sara Gibbons, Michael L'E. Orme, John F. Tjia, Marta Boffito, Catia Marzolini, Patrick G. Hoggard and Fiona M. Mulcahy. Their work appears in journals such as AIDS, Journal of Antimicrobial Chemotherapy, British Journal of Clinical Pharmacology, Antiviral Therapy and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact